Jones DR - Search Results

1

Relationship among histologic, radiologic, and biochemical assessments of hepatic steatosis: a study of human liver samples.

Vuppalanchi R, Cummings OW, Saxena R, Ulbright TM, Martis N, Jones DR, Bansal N, Chalasani N. Vuppalanchi R, et al. Among authors: jones dr. J Clin Gastroenterol. 2007 Feb;41(2):206-10. doi: 10.1097/01.mcg.0000225515.28536.3a. J Clin Gastroenterol. 2007. PMID: 17245221

2

Association between nonalcoholic hepatic steatosis and hepatic cytochrome P-450 3A activity.

Kolwankar D, Vuppalanchi R, Ethell B, Jones DR, Wrighton SA, Hall SD, Chalasani N. Kolwankar D, et al. Among authors: jones dr. Clin Gastroenterol Hepatol. 2007 Mar;5(3):388-93. doi: 10.1016/j.cgh.2006.12.021. Clin Gastroenterol Hepatol. 2007. PMID: 17368239

3

Relationship between differential hepatic microRNA expression and decreased hepatic cytochrome P450 3A activity in cirrhosis.

Vuppalanchi R, Liang T, Goswami CP, Nalamasu R, Li L, Jones D, Wei R, Liu W, Sarasani V, Janga SC, Chalasani N. Vuppalanchi R, et al. PLoS One. 2013 Sep 13;8(9):e74471. doi: 10.1371/journal.pone.0074471. eCollection 2013. PLoS One. 2013. PMID: 24058572 Free PMC article.

4

Pharmacokinetic and pharmacodynamic alterations in the Roux-en-Y gastric bypass recipients.

Tandra S, Chalasani N, Jones DR, Mattar S, Hall SD, Vuppalanchi R. Tandra S, et al. Among authors: jones dr. Ann Surg. 2013 Aug;258(2):262-9. doi: 10.1097/SLA.0b013e31827a0e82. Ann Surg. 2013. PMID: 23222033 Clinical Trial.

5

The effects of midodrine on the natriuretic response to furosemide in cirrhotics with ascites.

Misra VL, Vuppalanchi R, Jones D, Hamman M, Kwo PY, Kahi C, Chalasani N. Misra VL, et al. Aliment Pharmacol Ther. 2010 Oct;32(8):1044-50. doi: 10.1111/j.1365-2036.2010.04426.x. Aliment Pharmacol Ther. 2010. PMID: 20937051 Free PMC article. Clinical Trial.

6

Attribution of Nonalcoholic Steatohepatitis as an Etiology of Cirrhosis for Clinical Trials Eligibility: Recommendations From the Multi-stakeholder Liver Forum.

Noureddin M, Chan JL, Barradas K, Dimick-Santos L, Schabel E, Omokaro SO, Anania FA, Myers RP, Miller V, Sanyal AJ, Chalasani N; Liver Forum NASH Cirrhosis Working Group. Noureddin M, et al. Gastroenterology. 2020 Aug;159(2):422-427.e1. doi: 10.1053/j.gastro.2020.04.039. Epub 2020 Apr 27. Gastroenterology. 2020. PMID: 32353369 No abstract available.

7

Effect of CYP3A5 expression on vincristine metabolism with human liver microsomes.

Dennison JB, Jones DR, Renbarger JL, Hall SD. Dennison JB, et al. Among authors: jones dr. J Pharmacol Exp Ther. 2007 May;321(2):553-63. doi: 10.1124/jpet.106.118471. Epub 2007 Feb 1. J Pharmacol Exp Ther. 2007. PMID: 17272675

8

The contribution of intestinal and hepatic CYP3A to the interaction between midazolam and clarithromycin.

Gorski JC, Jones DR, Haehner-Daniels BD, Hamman MA, O'Mara EM Jr, Hall SD. Gorski JC, et al. Among authors: jones dr. Clin Pharmacol Ther. 1998 Aug;64(2):133-43. doi: 10.1016/S0009-9236(98)90146-1. Clin Pharmacol Ther. 1998. PMID: 9728893

9

Determination of cytochrome P450 3A4/5 activity in vivo with dextromethorphan N-demethylation.

Jones DR, Gorski JC, Haehner BD, O'Mara EM Jr, Hall SD. Jones DR, et al. Clin Pharmacol Ther. 1996 Oct;60(4):374-84. doi: 10.1016/S0009-9236(96)90194-0. Clin Pharmacol Ther. 1996. PMID: 8873685 Clinical Trial.

10

Intravenous diltiazem and CYP3A-mediated metabolism.

Masica AL, Azie NE, Brater DC, Hall SD, Jones DR. Masica AL, et al. Among authors: jones dr. Br J Clin Pharmacol. 2000 Sep;50(3):273-6. doi: 10.1046/j.1365-2125.2000.00249.x. Br J Clin Pharmacol. 2000. PMID: 10971313 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,392 results

Search Page